JAGSNPHARM

Wed, 29 Jul, 2026

• FilingJagsonpal Pharmaceuticals informed the exchange of a change in managementNSE ↗
• FilingQ1 FY2026–27 unaudited results filed for quarter ended 30 June 2026NSE ↗
• FilingRecord date set at 04-Sep-2026 for dividend payment by Jagsonpal PharmaceuticalsNSE ↗
• FilingQ1 FY2027 financial results filed for period ended June 30, 2026NSE ↗
• Filing

  Record date set for dividend payment on September 04, 2026

  BSE ↗
• Filing

  Unaudited financial results for Q1 FY2026-27 disclosed under Regulation 30

  BSE ↗
• Filing

  Q2 2026 unaudited financial results filed under Regulation 30, first disclosure of quarterly numbers

  BSE ↗
• Filing

  Q2 FY2027 unaudited results filed with limited review report, quarter ended June 30, 2026

  BSE ↗
• Filing

  Q1 FY2027 unaudited standalone financial results filed for quarter ended June 30, 2026

  BSE ↗

Wed, 22 Jul, 2026

• FilingBoard meeting scheduled for 29 July 2026 to consider and approve unaudited financial resultsBSE ↗

Fri, 17 Jul, 2026

• FilingJagsonpal Pharmaceuticals informs acquisition of Aequitas Healthcare Private LimitedNSE ↗
• Filing

  Company filed update on acquisition of Aequitas Healthcare Private Limited

  BSE ↗

Tue, 7 Jul, 2026

• FilingJagsonpal Pharmaceuticals acquires Aequitas Healthcare Private LimitedNSE ↗
• Filing

  Acquisition of Aequitas Healthcare Private Limited announced

  BSE ↗

Tue, 30 Jun, 2026

• FilingJagsonpal Pharmaceuticals filed disclosure under SEBI Takeover Regulations, Regulation 31(4), indicating a substantial…NSE ↗

Mon, 29 Jun, 2026

• News

  Jagsonpal Pharmaceuticals acquires 85% stake in Aequitas Healthcare for ₹21 crore

  cnbctv18.com ↗
• Filing

  Jagsonpal Pharmaceuticals acquires Aequitas Healthcare Private Limited

  NSE ↗
• Filing

  Jagsonpal Pharmaceuticals acquires Aequitas Healthcare Private Limited

  NSE ↗
• FilingCompany acquires Aequitas Healthcare Private LimitedBSE ↗
• FilingAcquisition of Aequitas Healthcare Private Limited announced under Regulation 30BSE ↗